Literature DB >> 17883992

The use of positive inotropes in end-of-life heart failure care.

Deirdre J Nauman1, Ray E Hershberger.   

Abstract

End-stage heart failure is associated with mortality equivalent to cancer, yet there is little information about palliative therapy for this disease. Chronic outpatient support with inotropes provides symptomatic relief and life extension for those select patients demonstrating dependence on positive inotropic therapy. The purpose of this review is to provide information about process and implementation of chronic outpatient support with inotropes in patients with end-stage heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883992     DOI: 10.1007/s11897-007-0035-0

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  23 in total

1.  The scale of heart failure: diagnosis and management issues for primary care.

Authors:  F D Hobbs
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Inotropic therapy for heart failure: an evidence-based approach.

Authors:  G M Felker; C M O'Connor
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

3.  Symptom burden at the end of life: hospice providers' perceptions.

Authors:  J S Kutner; C T Kassner; D E Nowels
Journal:  J Pain Symptom Manage       Date:  2001-06       Impact factor: 3.612

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium.

Authors:  Jeffrey J Teuteberg; Eldrin F Lewis; Anju Nohria; Sui W Tsang; James C Fang; Michael M Givertz; John A Jarcho; Gilbert H Mudge; Kenneth L Baughman; Lynne W Stevenson
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

6.  Patients with heart failure who die in hospice.

Authors:  Cheryl Hoyt Zambroski; Debra K Moser; Lynn P Roser; Seongkum Heo; Misook L Chung
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

7.  Dying trajectory in the last year of life: does cancer trajectory fit other diseases?

Authors:  J M Teno; S Weitzen; M L Fennell; V Mor
Journal:  J Palliat Med       Date:  2001       Impact factor: 2.947

Review 8.  End-of-life care in the treatment of heart failure in the elderly.

Authors:  John Arthur McClung
Journal:  Clin Geriatr Med       Date:  2007-02       Impact factor: 3.076

9.  A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.

Authors:  Susan C Brozena; Carol Twomey; Lee R Goldberg; Shashank S Desai; Brian Drachman; Andrew Kao; Eric Popjes; Ross Zimmer; Mariell Jessup
Journal:  J Heart Lung Transplant       Date:  2004-09       Impact factor: 10.247

10.  Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.

Authors:  K J Harjai; M R Mehra; H O Ventura; Y M Lapeyre; J P Murgo; D D Stapleton; F W Smart
Journal:  Chest       Date:  1997-11-05       Impact factor: 9.410

View more
  1 in total

Review 1.  Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Authors:  Eisuke Amiya; Masanobu Taya
Journal:  Clin Med Insights Cardiol       Date:  2018-01-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.